FDA Hits Guardian Drug for Lack of Quality Controls, Secure Data Post author:Sam Post published:April 11, 2017 Post category:Drug Industry Daily The FDA cited Guardian Drug Company over quality and data storage issues. Source: Drug Industry Daily You Might Also Like EMA Considers Using Big Data and Real-World Evidence in Approval Decisions February 22, 2017 NICE Backs Pfizer’s Bosulif After Cancer Fund Restructuring July 7, 2016 FDA Grounds Foshan Flying Medical Products August 21, 2017
